Larimar Therapeutics, Inc.
LRMR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$47,712 | -$26,182 | -$29,281 | -$28,824 |
| Dep. & Amort. | $88 | $87 | -$667 | $77 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1,785 | $1,828 | $1,834 | $2,410 |
| Change in WC | $17,480 | $5,420 | $1,634 | $5,761 |
| Other Non-Cash | -$394 | -$534 | -$60 | -$1,239 |
| Operating Cash Flow | -$28,753 | -$19,381 | -$26,540 | -$21,815 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$23 | -$19 | -$49 | -$179 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$3,458 | -$27,639 | -$52,503 | -$38,624 |
| Inv. Sales/Matur. | $36,500 | $46,500 | $67,000 | $58,000 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $33,019 | $18,842 | $14,448 | $19,197 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $65,287 | $0 | $0 | $36 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $65,287 | $0 | $0 | $36 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $69,553 | -$539 | -$12,092 | -$2,582 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $21,193 | $21,732 | $33,824 | $36,406 |
| End Cash | $90,746 | $21,193 | $21,732 | $33,824 |
| Free Cash Flow | -$28,776 | -$19,400 | -$26,589 | -$21,994 |